Snapshot

The Accelerated Approval Process pathway has been developed by the of India.

This pathway can be used where drugs intended to be used in life threatening or serious disease conditions or rare diseases and for drugs intended to be used in the diseases of special relevance to Indian scenario or unmet medical need in India, disaster or special defense use e.g. hemostatic and quick wound healing, enhancing oxygen carrying capacity, radiation safety, drugs for combating chemical, nuclear, biological infliction etc..

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

Target time assessment is .